CAS: 1803274-65-8
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
BAY-1436032 REF: AN-AG00AMHDCAS: 1803274-65-8 | ≥98% | A consultar | Mar 21 May 24 | |
BAY-1436032 REF: TM-TQ0042CAS: 1803274-65-8 | 99.65% | A consultar | Mar 28 May 24 | |
BAY-1436032 REF: 3D-DXC27465CAS: 1803274-65-8 | Min. 95% | A consultar | Lun 01 Jul 24 |
Ref: AN-AG00AMHD
1mg | 132,00 € | |
5mg | 323,00 € | |
10mg | 643,00 € | |
25mg | 520,00 € | |
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
BAY-1436032
CAS:1803274-65-8
BAY-1436032 is a novel, selective and orally available inhibitor of pan-mutant isocitrate dehydrogenase 1 (IDH1).
Fórmula:
C26H30F3N3O3
Pureza:
99.65%
Forma y color:
Solid
Peso molecular:
489.53
Ref: TM-TQ0042
1mg | 37,00 € | |
5mg | 78,00 € | |
10mg | 118,00 € | |
25mg | A consultar | |
50mg | A consultar | |
1ml*10 (DMSO) | 83,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Mayo de 2024
BAY-1436032
CAS:1803274-65-8
BAY-1436032 is a novel small molecule inhibitor of CXCR4. It has been shown to be …
Fórmula:
C26H30F3N3O3
Pureza:
Min. 95%
Peso molecular:
489.53 g/mol
Ref: 3D-DXC27465
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 1 de Julio de 2024